EpiPen Raises Prices, Gives Execs Huge Raises
- Thread starter MI2AZ
- Start date
News article asking why they can't refill those epipens.
http://www.usatoday.com/story/news/...s-new-epinephrine-after-they-expire/89339136/
They could have designed them that way initially, just change out the cartridge, but that would have lost them profits.
http://www.usatoday.com/story/news/...s-new-epinephrine-after-they-expire/89339136/
They could have designed them that way initially, just change out the cartridge, but that would have lost them profits.
But that is about the same thing. It is the medicine that is expiring. There needs to be a longer shelf life.
Not quite sure how this pen works, but I take a different pen for diabetes and there is a liquid, and powder.
you have to twist the pen to get the two to mix, then twist again to "arm" it. If I am not mistaken either this one, or another epipen talks to you, so it is battery operated, that is also part of the reason why you just cant reload it.
Not quite sure how this pen works, but I take a different pen for diabetes and there is a liquid, and powder.
you have to twist the pen to get the two to mix, then twist again to "arm" it. If I am not mistaken either this one, or another epipen talks to you, so it is battery operated, that is also part of the reason why you just cant reload it.
Good Times Good Times
Active Member
Greed gives rise to selfish or wicked actions.
Last edited:
Good Times Good Times
Active Member
I couldn't agree more.
From my phone, its easier than modifying my own post.Never seen anyone quote himself, you must need some of these meds
But on your point, the margin should be capped once the R and D is paid for. That would include paying off the initial investors.
everyone would still get money, but it would be at that capped margin.
You aren't talking about a private corporation then. Companies wouldn't go into phamas if the margins are capped. I
People generally don't innovate just for the sake of innovation. They want to make money. Maybe take that money and innovate new things. Patents allow such protection.
Hrm. I didn't get that from the article. Sterilization I guess is the biggest issue.
My father quit using novolog pens because it got too expensive. He went back to regular insulin. I see lots of complaints about about insulin prices too.
No, the last sentence I wrote after the link was my thought on the subject.
Greg T.
The Jizz Slinger
X millions of users = volume
Not really.
Monster Pike
Member
Why not?
This is not a product that they will stock up on just because the price is low. They expire to quickly for that.
They might buy what they need ie 12 for 1 a month instead of 4 and chancing it because of price.
They might buy what they need ie 12 for 1 a month instead of 4 and chancing it because of price.
Because the demand is pretty well fixed. It's not a drug that has to be purchased month after month. It's more like an asthma emergency inhaler.
Good Times Good Times
Active Member
Monster Pike
Member
That still doesn't tell me how X millions of users doesn't equal volume.
What is "volume" then, times these "X million users"?
What is "volume" then, times these "X million users"?
Greg T.
The Jizz Slinger
Not true. They expire and need to be replaced. Milions expired = millions replaced.
Heather Bresch saw her salary leap to $18.9 million from $2.4 million
President Rajiv Malik's base pay jumped 11.1% to $1 million and Chief Commercial Officer Anthony Mauro’s rose 13.6% to $625,000, NBC reports,
Can we not agree that if they can afford to give the execs those amounts of pay raises, they are making enough profit?
President Rajiv Malik's base pay jumped 11.1% to $1 million and Chief Commercial Officer Anthony Mauro’s rose 13.6% to $625,000, NBC reports,
Can we not agree that if they can afford to give the execs those amounts of pay raises, they are making enough profit?